Listed

BridgeBio Pharma, Inc.

BBIONasdaqCIK 1743881HealthcareFiscal year ends Dec 31

Reports and events: 183 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

BridgeBio Pharma, Inc., Reports and events
FiledFormWhat it isAccession number
2020-04-2916:46 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation0001193125-20-126364
2020-04-2217:22 ETDEF 14AProxy statementPeriod 2020-06-020001140361-20-009469
2020-03-2406:06 ET8-K8.01 Other events0001193125-20-083085
2020-03-1021:52 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-20-067542
2020-03-0606:30 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-20-063716
2020-03-0407:21 ET8-K8.01 Other events0001193125-20-060890
2020-03-0306:07 ET10-KAnnual reportPeriod 2019-12-310001564590-20-008260
2020-03-0208:44 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-20-058049
2020-02-1917:07 ET8-K5.02 Departure or appointment of officers or directors0001193125-20-042081
2020-01-0716:17 ET8-K1.01 Entry into a material agreement0001193125-20-003038
2019-12-2616:33 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-19-323511
2019-12-1706:07 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-19-315521
2019-11-1916:30 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-19-295582
2019-11-0806:06 ET10-QQuarterly reportPeriod 2019-09-300001564590-19-041986
2019-10-1509:27 ETSC 13D/AOwnership report, active investor, amended0001193125-19-267356
2019-10-1117:02 ET8-K5.02 Departure or appointment of officers or directors0001193125-19-266824
2019-09-1206:06 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-19-243348
2019-08-1406:07 ET10-QQuarterly reportPeriod 2019-06-300001564590-19-031927
2019-08-0816:11 ETSC 13D/AOwnership report, active investor, amended0001193125-19-216833
2019-07-1017:06 ETSC 13DOwnership report, active investor0001140361-19-012746
2019-07-0921:25 ETSC 13D/AOwnership report, active investor, amended0001193125-19-190741
2019-07-0816:46 ETSC 13DOwnership report, active investor0000903423-19-000277
2019-07-0316:34 ET8-K5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-19-189260
2019-06-2621:09 ETS-1/ARegistration statement, amended0001193125-19-181551
2019-06-2407:12 ETS-1/ARegistration statement, amended0001193125-19-179321
2019-06-1706:09 ETS-1/ARegistration statement, amended0001193125-19-174178
2019-06-1106:26 ETS-1/ARegistration statement, amended0001193125-19-169677
2019-05-3019:16 ETSC 13D/AOwnership report, active investor, amended0001193125-19-159860
2019-05-2416:46 ETS-1Registration statement0001193125-19-157100
2018-12-1317:45 ETSC 13D/AOwnership report, active investor, amended0001193125-18-347912
2018-12-1119:27 ETSC 13D/AOwnership report, active investor, amended0001193125-18-346386
2018-12-0720:50 ETSC 13D/AOwnership report, active investor, amended0001193125-18-344046
2018-08-0108:02 ETSC 13DOwnership report, active investor0001193125-18-233959

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 12, 2026, 17:56 ET. Listed shows no prices and gives no investment advice.